Trial Profile
A single centre, prospective cohort study will evaluate efficacy and safety of Hepatitis A vaccine inactivated (Avaxim 80U Pediatric) in healthy children in Argentina
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- 04 Feb 2016 New trial record